Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia

Background & Aims. This paper presents the results of the observational study of ibrutinib in patients with chronic lymphocytic leukemia (CLL), conducted in SP Botkin Municipal Clinical Hospital. The main objective was the analysis of complications of ibrutinib and identification of factors, influen...

全面介紹

書目詳細資料

Principais autores:	Evgenii Aleksandrovich Nikitin, E. A. Dmitrieva, M. A. Panteleev, E. I. Emelina, V. L. Ivanova, Yu. B. Kochkareva, E. G. Arshanskaya, I. E. Lazarev, E. E. Markova, L. A. Mukha, N. G. Novitskaya, M. M. Pankrashkina, V. V. Glazunova, A. V. Shubina, S. A. Chernysh, N. K. Khuazheva, E. V. Naumova, S. A. Lugovskaya, M. E. Pochtar’, T. N. Obukhova, O. Yu. Vinogradova, G. E. Gendlin, V. V. Ptushkin
格式:	Artigo
語言:	Russo
出版:	Practical Medicine Publishing House 2017-07-01
叢編:	Клиническая онкогематология
主題:	chronic lymphocytic leukemia del 17p tp53 refractory cll ibrutinib bleeding atrial fibrillation
在線閱讀:	https://bloodjournal.ru/index.php/coh/article/view/424
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!